Exchange: NASDAQ·Updated 10:03 AM EDT
RDNT logo

RDNTRadnet Inc

$69.32
$0.57
(0.83%)
Today
EarningsAug 6
Mkt Cap$5.41B
Vol29,225.00
News
all
press releases
RDNT's Unit DeepHealth Expands AI Breast Suite With FDA-Cleared Tools
RadNet's DeepHealth gains FDA clearances for AI breast imaging tools that assess cardiovascular risk and compare prior mammograms.
Zacks
News Placeholder
More News
News Placeholder
Do Options Traders Know Something About RadNet Stock We Don't?
Investors need to pay close attention to RDNT stock based on the movements in the options market lately.
Zacks
News Placeholder
Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts
Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts PR Newswire NEW YORK, May 19...
PR Newswire
News Placeholder
RadNet Q1 Earnings Call Highlights
RadNet Q1 Earnings Call Highlights...
Yahoo! Finance: News
News Placeholder
RadNet (RDNT) Q1 2026 Earnings Transcript
RadNet (RDNT) Q1 2026 Earnings Transcript...
Yahoo! Finance: News
News Placeholder
Astrana Health, Inc. (ASTH) Surpasses Q1 Earnings and Revenue Estimates
Astrana Health, Inc. (ASTH) delivered earnings and revenue surprises of +155.17% and +2.92%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Elanco Animal Health Incorporated (ELAN) Beats Q1 Earnings and Revenue Estimates
Elanco Animal Health (ELAN) delivered earnings and revenue surprises of +16.28% and +6.93%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
RadNet, Inc. (NASDAQ:RDNT) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of RadNet, Inc. (NASDAQ:RDNT - Get Free Report) have been given a consensus recommendation of 'Moderate Buy' by the ten brokerages that are presently covering the firm, Marketbeat reports. One...
MarketBeat
News Placeholder
DaVita HealthCare (DVA) Tops Q1 Earnings and Revenue Estimates
DaVita HealthCare (DVA) delivered earnings and revenue surprises of +19.09% and +3.52%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Addus HomeCare (ADUS) Q1 Earnings Top Estimates
Addus HomeCare (ADUS) delivered earnings and revenue surprises of +6.86% and -0.35%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
<
1
2
...
>

Advertisement|Remove ads.